+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and their use in preventing carotid disease



Statins and their use in preventing carotid disease



Current Atherosclerosis Reports 11(4): 309-314



Carotid disease may be evaluated by surrogate outcomes, such as intima-media thickness and carotid plaque features, and by clinical end points. Statins stop progression or may induce regression of intima-media thickness, and statins may also stop plaque growth or even induce reduction of plaque volume. Areas rich in lipids within plaques may be reduced in size and/or in number of inflammatory cells. Ultrasound reflectivity may be reduced by statin treatment, indicating less lipid/inflammatory content. Finally, statins appear to reduce the risk of all cardiovascular events (eg, stroke, myocardial infarction, need for revascularization) in patients with carotid stenosis. This review summarizes and discusses the existing data.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911905

Download citation: RISBibTeXText

PMID: 19500495

DOI: 10.1007/s11883-009-0047-1


Related references

How should we balance individual and population benefits of statins for preventing cardiovascular disease?. Bmj 342: C6244-C6244, 2011

Pleiotropic effect of statins in preventing progression of chronic renal disease. Polskie Archiwum Medycyny Wewnetrznej 110(4): 1181-1183, 2004

Effects of statins on carotid disease and stroke. Current Opinion in Lipidology 10(6): 535-541, 2000

Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease. Current Opinion in Nephrology and Hypertension 20(2): 146-152, 2011

Statins and intra-plaque angiogenesis in carotid artery disease. Atherosclerosis 192(2): 455-456, 2007

Statins: an essential component in the management of carotid artery disease. Journal of Vascular Surgery 46(2): 373-386, 2007

On the statins, correcting plasma lipid levels, and preventing the clinical sequelae of atherosclerotic coronary heart disease. American Journal of Cardiology 81(8): 1045-1046, 1998

Statins reduce levels of metalloproteinases in patients with carotid occlusive disease. International Angiology 33(6): 530-539, 2015

Use of statins for preventing cardiovascular and renal outcomes in patients with chronic kidney disease excluding dialysis: guideline from the Italian Society of Nephrology. Giornale Italiano di Nefrologia 24 Suppl 37(): S83-S90, 2007

Preventing stroke from carotid artery disease. Journal Of Cardiovascular Medicine: 1085-1106, 1981

Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins. American Journal of Cardiology 98(9): 1170-1171, 2006

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. Journal of the American College of Cardiology 52(25): 2198-2205, 2009

The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins?. Atherosclerosis 213(1): 8-20, 2011

Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials. Journal of Cardiovascular Pharmacology and Therapeutics 15(3): 268-273, 2010

Effect of statins on early and late clinical outcomes of carotid endarterectomy and the rate of post-carotid endarterectomy restenosis. Journal of the American College of Surgeons 220(4): 481-487, 2015